ReviewOncology letters2020
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective.
Vera Loizzi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it